Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gene-guided N-acetyl Cysteine for Prophylaxis of Anti-tuberculous Drug- Induced Hepatitis: A Randomized Controlled Trial

NCT06484530 is registered in ClinicalTrials.gov with Mahidol University as lead sponsor.

NCT NCT06484530
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06484530 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gene-guided N-acetyl Cysteine for Prophylaxis of Anti-tuberculous Drug- Induced Hepatitis: A Randomized Controlled Trial
Lead sponsor
Mahidol University
Phase
Phase 4
Overall status
Unknown status
Start date
March 12, 2024
Completion date
September 18, 2024
Enrollment
116 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ethambutol toxicity, isoniazid toxicity, n-acetylcysteine, nat2 polymorphism, nat2 rapid acetylator status, nat2 slow acetylator status, pyrazinamide adverse reaction, rifampicin toxicity, tuberculosis (tb)